Anita Brikman/thefemword.world
Jul 21, 2026, 00:55
Anita Brikman on PPTA’s First-Half 2026 Achievements
Plasma Protein Therapeutics Association (PPTA) shared on LinkedIn:
”As 2026 reaches its midpoint, PPTA and its members have made significant progress in strengthening patient access to plasma-derived therapies worldwide.
From advancing advocacy efforts in North America and Europe to expanding global stakeholder engagement and supporting important regulatory initiatives, the first half of the year has demonstrated the power of collaboration across the plasma community.
Watch as PPTA President and CEO Anita Brikman reflects on key achievements from the first six months of 2026, then read the full report.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Jul 21, 2026, 11:48A Century of VWD: Redefining Its Role Beyond Hemostasis
-
Jul 21, 2026, 08:43Joy Duemke: Optimizing Stem Cell Collection for Gene Therapy Success
-
Jul 21, 2026, 07:55A New Era of Precision Imaging for Venous Thromboembolism – JTH
-
Jul 21, 2026, 07:43How to Monitor and Manage Unfractionated Heparin in Practice – JTH
-
Jul 21, 2026, 07:23Arthur Allen: Advancing Outpatient Antithrombotic Stewardship Through ADAPT
-
Jul 21, 2026, 03:19Where Does Stroke Treatment Go Next on The Latest ESOC 2026 TV Studio Session – ESO
-
Jul 21, 2026, 03:09Francesca Palandri: New Insights Into Anemia Management in Myelofibrosis
-
Jul 21, 2026, 01:57A New Approach to Understanding Plasmin Generation and Fibrinolysis – RPTH Journal
-
Jul 21, 2026, 01:52Maria Diaz Alonso: Delivering My First International Oral Presentation at ISTH 2026